Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
-696K
-
Total reported value, excl. options
-
$3.97B
-
Value change
-
-$71.8M
-
Put/Call ratio
-
2.2
-
Number of buys
-
125
-
Number of sells
-
-122
-
Price
-
$74.85
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q1 2021
315 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q1 2021.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 62.7M outstanding shares and own 84.74% of the company stock.
Largest 10 shareholders include FMR LLC (8.76M shares), WELLINGTON MANAGEMENT GROUP LLP (5.17M shares), VANGUARD GROUP INC (4.76M shares), BlackRock Inc. (3.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.41M shares), JANUS HENDERSON GROUP PLC (1.87M shares), D. E. Shaw & Co., Inc. (1.87M shares), Bellevue Group AG (1.81M shares), Artisan Partners Limited Partnership (1.56M shares), and Invesco Ltd. (1.49M shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.